Patients with Alzheimer’s dementia and related disorders who also have delirium incur greater health care costs

Alzheimer’s Dementia and Related Disorders (ADRD) affects upwards of 5 million people in the United States, with no known treatments to stop or prevent its progression. Associated with these diagnoses are costly health care bills, which are especially costly for ADRD patients that additionally experience delirium: a preventable mental deterioration.